BioSpace News Archive

Teva Announces Launch of its Generic Version of Canasa ® (mesalamine) Suppositories To Treat Adults with Active Ulcerative Proctitis (ulcerative rectal colitis), in the United States

The XENDEE Microgrid Cloud Computing Platform has been awarded the gold medal in the 2021 Edison Awards for Critical Human Infrastructure.

Walgreens Boots Alliance, Inc. announced the pricing terms of the previously announced cash tender offer for certain outstanding senior notes listed in Table 1 below.

It’s the first foray into the world of NFTs for “Hollywood’s Biggest Night” — the new technology that allows people to own a unique piece of digital content — and the social impact couldn’t be any bigger.

Amgen (NASDAQ:AMGN) today announced Otezla® (apremilast) improved measures of disease severity in adults with mild-to-moderate plaque psoriasis regardless of their Body Surface Area (BSA) affected by the disease, according to findings from the placebo-controlled, Phase 3 ADVANCE trial.

EnPro Industries, Inc. (NYSE: NPO) intends to release financial results for the first quarter of 2021 on Friday May 7, 2021, before the opening of trading on the New York Stock Exchange. The company will hold a conference call to discuss the results at 8:30 a.m. Eastern Time that morning.

Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that Dr. Jorge Hernando Ulloa, the Principal Investigator for HJLI first-in-human VenoValve study in Bogota, Colombia, presented one year data this past week at the Charing Cross International Symposium.

Leaders in precision gut microbiome science, Microba Life Sciences have demonstrated how their proprietary Microba Community Profiler compares to other metagenomic profilers, with the study published in Frontiers in Microbiology.

This press release is being issued in connection with the filing of an early warning report (the “Early Warning Report”) pursuant to the requirements of National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues regarding the acquisition (the “Acquisition”) of securities of Avisa Diagnostics Inc.

Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish fourth quarter and fiscal year 2021 financial results at 6:00 am EDT on Thursday , May 13, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on May 13 , 2021.